have documented a novel link between CDK5 and glioma CSCs,[10] the mechanism underlying CDK5‐mediated TNBC stemness remains unclear and it is still unknown whether CDK5 blockade efficiently enhances immunotherapy in TNBC. This evidence concerns the gene CDK5 and glioma.